Biological effective dose evaluation in gynaecological brachytherapy: LDR and HDR treatments, dependence on radiobiological parameters, and treatment optimisation

被引:10
作者
Bianchi C. [1 ]
Botta F. [2 ]
Conte L. [3 ]
Vanoli P. [4 ]
Cerizza L. [4 ]
机构
[1] Servizio di Fisica Sanitaria, Ospedale di Circolo, Varese 21100
[2] Scuola di Specializzazione in Fisica Sanitaria, Università degli Studi di Milano, Milano
[3] Dipartimento di Scienze Cliniche e Biologiche, Università dell'Insubria, Varese
[4] Divisione di Radioterapia, Ospedale di Circolo, Varese
关键词
BED; Brachytherapy; Gynaecological; Optimisation;
D O I
10.1007/s11547-008-0291-4
中图分类号
学科分类号
摘要
Purpose. This study was undertaken to compare the biological efficacy of different high-dose-rate (HDR) and low-dose-rate (LDR) treatments of gynaecological lesions, to identify the causes of possible nonuniformity and to optimise treatment through customised calculation. Materials and methods. The study considered 110 patients treated between 2001 and 2006 with external beam radiation therapy and/or brachytherapy with either LDR (afterloader Selectron, 137Cs) or HDR (afterloader microSelectron Classic, 192Ir). The treatments were compared in terms of biologically effective dose (BED) to the tumour and to the rectum (linear-quadratic model) by using statistical tests for comparisons between independent samples. Results. The difference between the two treatments was statistically significant in one case only. However, within each technique, we identified considerable nonuniformity in therapeutic efficacy due to differences in fractionation schemes and overall treatment time. To solve this problem, we created a Microsoft Excel spreadsheet allowing calculation of the optimal treatment for each patient: best efficacy (BED tumour) without exceeding toxicity threshold (BEDrectum). Conclusions. The efficacy of a treatment may vary as a result of several factors. Customised radiobiological evaluation is a useful adjunct to clinical evaluation in planning equivalent treatments that satisfy all dosimetric constraints. © 2008 Springer-Verlag.
引用
收藏
页码:1068 / 1078
页数:10
相关论文
共 10 条
[1]  
Sminia P., Schneider C.J., Fowler J.F., The optimal fractionatio size in high-dose-rate brachytherapy: Dependency on tissue repair kinetics and low-dose rate, Int J Rad Oncol Biol Phys, 52, pp. 844-849, (2002)
[2]  
Dale R., Coles I.P., Deehan C., Calculation of Integrated Biological Response in Brachytherapy, Int J Rad Oncol Biol Phys, 38, pp. 633-642, (1997)
[3]  
Dale R.G., The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy, Br J Radiol, 58, pp. 515-528, (1985)
[4]  
Dale R.G., Possible dose-rate dependence of ricovery kinetics as deduced from a preliminary analysis of the effects of fractionated irradiations at varying dose rates, Br J Radiol, 61, pp. 153-157, (1987)
[5]  
Deehan C., O'Donoghue J.A., Mould R.F., Battermann J.J., Martinez A.A., Speiser B.L., Biological equivalence of LDR and HDR brachytherapy, Brachytherapy from Radium to Optimization, pp. 19-33, (1994)
[6]  
Gasinska A., Fowler J.F., Lind B.K., Urbanski K., Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone, Acta Oncologica, 43, pp. 657-666, (2004)
[7]  
Guerrero M., Li X.A., Halftime for repair of sublethal damage in normal bladder and rectum: An analysis of clinical data from cervix brachytherapy, Phys Med Biol, 51, pp. 4063-4071, (2006)
[8]  
Nag S., Orton C., Young D., Erickson B., The American Brachytherapy Society survey of brachytherapy practice for carcinoma of the cervix in the United States, Gynecol Oncol, 73, pp. 111-118, (1999)
[9]  
Leborgne F., High dose rate brachytherapy at 14 Gy per hour to point A: Preliminary results of a prospectively designed schedale for cancer of the cervix based on the linearquadratic model, Int J Gynecol Cancer, 11, pp. 445-453, (2001)
[10]  
Hyun Kim T., Choi J., Park S.Y., Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma, Cancer, 104, pp. 1304-1311, (2005)